Sculptra® is approved by the FDA for restoration and/or correction of the signs of facial fat loss, or lipoatrophy, in people with human immunodeficiency virus. In a clinical study, the effects lasted for up to 2 years after the first treatment session in most patients.
The results from Sculptra® are not immediate. Sculptra® provides a gradual increase in skin thickness. Your doctor will determine the number of additional injections needed.